Mestan
Gerhard Mestan, Vienna AT
Patent application number | Description | Published |
---|---|---|
20150203693 | FLAME-RETARDANT POLYMER COMPOSITION - The invention relates to a flame-proofed polymeric composition suitable for coating workpieces, containing a vinyl acetate-containing thermoplastic polymer and an unsaturated elastomer containing double bonds as polymeric components, wherein the polymeric components are present in the form of a homogeneous polymeric mixture, and a mixture matrix vulcanised exclusively by a sulphur or sulphur-containing crosslinking system is formed, wherein the sulphur crosslinking system extends across the entire matrix and permeates the matrix completely, and—at least one flame retardant or a combination of flame retardants. The invention further relates to articles produced therefrom, and to composite elements coated with this composition and to a method for producing the same. | 07-23-2015 |
Juergen Mestan, Denzlingen DE
Patent application number | Description | Published |
---|---|---|
20080312252 | Combination of Organic Compounds - The invention provides a pharmaceutical combination comprising: | 12-18-2008 |
20100022569 | INHIBITORS OF TYROSINE KINASES - The present invention relates to the use of pyrimidylaminobenzamide compounds for the preparation of a drug for the treatment of diseases that respond to modulation of Ephrin receptor kinase, especially EphB4, activity, especially for the curative and/or prophylactic treatment of proliferative diseases, and to a method of treating diseases that respond to modulation of kinase activity, especially Ephrin receptor kinase activity. | 01-28-2010 |
20100190800 | COMBINATON OF PYRIMIDYLAMINOBENZAMIDE COMPOUNDS AND IMATINIB FOR TREATING OR PREVENTING PROLIFERATIVE DISEASES - The invention provides a pharmaceutical combination comprising: | 07-29-2010 |
Jürgen Mestan, Denzlingen DE
Patent application number | Description | Published |
---|---|---|
20080227800 | Pyrimidylaminobenzamide Derivatives for Hypereosinophilic Syndrome - The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of FIP1L1-PDGFRα-induced or TEL-PDGFRβ-induced myeloproliferative diseases, especially for the curative and/or prophylactic treatment of hypereosinophilic syndrome and hypereosinophilic syndrome with resistance to imatinib, and to a method of treating hypereosinophilic syndrome, chronic eosinophilic leukemia and hypereosinophilic syndrome with resistance to imatinib, or other diseases associated with FIP1L1-PDGFRα, TEL-PDGFRβ or similar mutations that activate PDGFR. | 09-18-2008 |
20100210673 | PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR SYSTEMIC MASTOCYTOSIS - The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of systemic mastocytosis. | 08-19-2010 |
Jürgen Mestan, Denzlingen DE
Patent application number | Description | Published |
---|---|---|
20100210673 | PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR SYSTEMIC MASTOCYTOSIS - The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of systemic mastocytosis. | 08-19-2010 |